Literature DB >> 10884680

Latest advances in the development of dry powder inhalers.

.   

Abstract

The current market for dry powder inhalers (DPIs) has over 20 devices in present use and at least another 30 under development. Clinicians recognize that DPIs are a suitable alternative to pressurized metered dose inhalers (pMDIs) for some patients but the relative performance of devices is often unclear. The problem is compounded by the need to reformulate pMDIs with new propellants, introducing further products to the market with associated variations in performance. This article reviews the DPIs currently available, the driving forces governing new designs, and the claimed advantages of DPIs in the development pipeline.

Entities:  

Year:  2000        PMID： 10884680     DOI： 10.1016/s1461-5347(00)00275-3

Source DB:  PubMed          Journal:  Pharm Sci Technol Today        ISSN： 1461-5347


  10 in total

1.  Powder properties and their influence on dry powder inhaler delivery of an antitubercular drug.

Authors:  Vasu V Sethuraman; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2002       Impact factor: 3.246

Review 2.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

3.  Artificial neural network prediction of aerosol deposition in human lungs.

Authors:  Javed Nazir; David J Barlow; M Jayne Lawrence; Christopher J Richardson; Ian Shrubb
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

4.  Chapter 9 - Nanoliposomal dry powder formulations.

Authors:  Gaurang Patel; Mahavir Chougule; Mandip Singh; Ambikanandan Misra
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

5.  Aerosolization characteristics of dry powder inhaler formulations for the excipient enhanced growth (EEG) application: effect of spray drying process conditions on aerosol performance.

Authors:  Yoen-Ju Son; P Worth Longest; Michael Hindle
Journal:  Int J Pharm       Date:  2013-01-10       Impact factor: 5.875

6.  Evaluation and modification of commercial dry powder inhalers for the aerosolization of a submicrometer excipient enhanced growth (EEG) formulation.

Authors:  Yoen-Ju Son; P Worth Longest; Geng Tian; Michael Hindle
Journal:  Eur J Pharm Sci       Date:  2013-04-19       Impact factor: 4.384

7.  Development of spray dried liposomal dry powder inhaler of Dapsone.

Authors:  Mahavir Chougule; Bijay Padhi; Ambikanandan Misra
Journal:  AAPS PharmSciTech       Date:  2008-01-09       Impact factor: 3.246

Review 8.  Inhalation drug delivery devices: technology update.

Authors:  Mariam Ibrahim; Rahul Verma; Lucila Garcia-Contreras
Journal:  Med Devices (Auckl)       Date:  2015-02-12

9.  Medical Device-related Counseling Practice and Barriers among Sudanese Pharmacists: A Questionnaire-Based Study.

Authors:  Ahmed Ibrahim Fathelrahman
Journal:  J Res Pharm Pract       Date:  2021-12-25

10.  A review of formulations and preclinical studies of inhaled rifampicin for its clinical translation.

Authors:  Prakash Khadka; Jack Dummer; Philip C Hill; Rajesh Katare; Shyamal C Das
Journal:  Drug Deliv Transl Res       Date:  2022-09-21       Impact factor: 5.671
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.